Cardiff Park Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Cardiff Park Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-353	Closed	-$205K	–	385
2025 Q4	$205K	Buy	+353	New	+$200K	0.02%	268
2024 Q4	–	Sell	-405	Closed	-$251K	–	354
2024 Q3	$251K	Sell	405 -37	-8%	-$21.9K	0.02%	227
2024 Q2	$244K	Buy	442 +4	+0.9%	+$2.29K	0.02%	222
2024 Q1	$255K	Sell	438 -3	-0.7%	-$1.68K	0.02%	223
2023 Q4	$234K	Buy	+441	New	+$213K	0.03%	208

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cardiff Park Advisors's TMO Position: Q1 2026 in Review

Cardiff Park Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 353 shares — an estimated $205K sold.

Cardiff Park Advisors first reported a position in TMO in Q4 2023 and held it in 5 quarters. The position peaked at $255K in Q1 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Cardiff Park Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Cardiff Park Advisors sold 353 Thermo Fisher Scientific shares in Q1 2026, an estimated $205K.
Cardiff Park Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 5 quarters.
Cardiff Park Advisors's Thermo Fisher Scientific position peaked at $255K in Q1 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.